Home » Topics » Regulatory

Regulatory
RSS

Schering-Plough seeks FDA approval for PEG-Intron/Rebetol combination

Feb. 7, 2001

FDA extends approval of Toprol-XL to include heart failure

Feb. 7, 2001

FDA approves tablet formulation of CollaGenex's Periostat

Feb. 6, 2001

Formulation of glibenclamide with excellent percutaneous absorption

Feb. 6, 2001

Orion claims new use for levosimendan

Feb. 6, 2001

E.U. approves Remicade for broader RA indication

Feb. 6, 2001

Compositions and methods of treating obesity claimed by Knoll

Feb. 5, 2001

FDA issues approvable letter for Visudyne

Feb. 5, 2001

FDA approves vagus nerve stimulation trial for anxiety disorders

Feb. 5, 2001

Dimethaid begins mutual recognition procedure in E.U. for Pennsaid

Feb. 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...